Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: Q4QHJ1
Term | Name | Level | Count |
---|---|---|---|
GO:0006066 | alcohol metabolic process | 3 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006729 | tetrahydrobiopterin biosynthetic process | 6 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009058 | biosynthetic process | 2 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0018130 | heterocycle biosynthetic process | 4 | 11 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 11 |
GO:0019751 | polyol metabolic process | 4 | 11 |
GO:0034311 | diol metabolic process | 5 | 11 |
GO:0034312 | diol biosynthetic process | 6 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0042558 | pteridine-containing compound metabolic process | 4 | 11 |
GO:0042559 | pteridine-containing compound biosynthetic process | 5 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044249 | cellular biosynthetic process | 3 | 11 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 11 |
GO:0044281 | small molecule metabolic process | 2 | 11 |
GO:0044283 | small molecule biosynthetic process | 3 | 11 |
GO:0046146 | tetrahydrobiopterin metabolic process | 5 | 11 |
GO:0046165 | alcohol biosynthetic process | 4 | 11 |
GO:0046173 | polyol biosynthetic process | 5 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 11 |
GO:1901576 | organic substance biosynthetic process | 3 | 11 |
GO:1901615 | organic hydroxy compound metabolic process | 3 | 11 |
GO:1901617 | organic hydroxy compound biosynthetic process | 4 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity | 5 | 11 |
GO:0016829 | lyase activity | 2 | 11 |
GO:0016835 | carbon-oxygen lyase activity | 3 | 11 |
GO:0016836 | hydro-lyase activity | 4 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 224 | 228 | PF00656 | 0.555 |
CLV_C14_Caspase3-7 | 245 | 249 | PF00656 | 0.594 |
CLV_C14_Caspase3-7 | 74 | 78 | PF00656 | 0.592 |
CLV_NRD_NRD_1 | 179 | 181 | PF00675 | 0.455 |
CLV_NRD_NRD_1 | 187 | 189 | PF00675 | 0.475 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.417 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.289 |
CLV_PCSK_KEX2_1 | 187 | 189 | PF00082 | 0.441 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.417 |
CLV_PCSK_PC1ET2_1 | 163 | 165 | PF00082 | 0.289 |
CLV_PCSK_PC7_1 | 159 | 165 | PF00082 | 0.289 |
CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.422 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.529 |
DEG_SPOP_SBC_1 | 84 | 88 | PF00917 | 0.723 |
DOC_ANK_TNKS_1 | 186 | 193 | PF00023 | 0.508 |
DOC_USP7_MATH_1 | 250 | 254 | PF00917 | 0.596 |
DOC_USP7_MATH_1 | 84 | 88 | PF00917 | 0.723 |
DOC_USP7_MATH_1 | 9 | 13 | PF00917 | 0.543 |
DOC_WW_Pin1_4 | 235 | 240 | PF00397 | 0.616 |
LIG_14-3-3_CanoR_1 | 195 | 203 | PF00244 | 0.441 |
LIG_14-3-3_CanoR_1 | 2 | 8 | PF00244 | 0.669 |
LIG_14-3-3_CanoR_1 | 230 | 240 | PF00244 | 0.553 |
LIG_Actin_WH2_2 | 165 | 182 | PF00022 | 0.351 |
LIG_Actin_WH2_2 | 204 | 220 | PF00022 | 0.494 |
LIG_BRCT_BRCA1_1 | 154 | 158 | PF00533 | 0.271 |
LIG_FHA_1 | 148 | 154 | PF00498 | 0.289 |
LIG_FHA_1 | 217 | 223 | PF00498 | 0.619 |
LIG_FHA_2 | 116 | 122 | PF00498 | 0.299 |
LIG_LIR_Gen_1 | 113 | 124 | PF02991 | 0.259 |
LIG_LIR_Gen_1 | 29 | 40 | PF02991 | 0.519 |
LIG_LIR_Gen_1 | 5 | 15 | PF02991 | 0.557 |
LIG_LIR_Nem_3 | 113 | 119 | PF02991 | 0.253 |
LIG_LIR_Nem_3 | 136 | 142 | PF02991 | 0.252 |
LIG_LIR_Nem_3 | 155 | 161 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 174 | 179 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 29 | 35 | PF02991 | 0.521 |
LIG_LIR_Nem_3 | 5 | 10 | PF02991 | 0.619 |
LIG_LYPXL_yS_3 | 139 | 142 | PF13949 | 0.306 |
LIG_PCNA_yPIPBox_3 | 195 | 203 | PF02747 | 0.512 |
LIG_Pex14_1 | 130 | 134 | PF04695 | 0.288 |
LIG_PTB_Apo_2 | 170 | 177 | PF02174 | 0.362 |
LIG_PTB_Phospho_1 | 170 | 176 | PF10480 | 0.289 |
LIG_SH2_CRK | 176 | 180 | PF00017 | 0.383 |
LIG_SH2_SRC | 152 | 155 | PF00017 | 0.289 |
LIG_SH2_STAP1 | 154 | 158 | PF00017 | 0.261 |
LIG_SH2_STAT5 | 123 | 126 | PF00017 | 0.278 |
LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.288 |
LIG_SH3_3 | 94 | 100 | PF00018 | 0.700 |
LIG_TRAF2_1 | 198 | 201 | PF00917 | 0.441 |
LIG_TRAF2_1 | 221 | 224 | PF00917 | 0.560 |
LIG_ULM_U2AF65_1 | 180 | 185 | PF00076 | 0.453 |
LIG_WRC_WIRS_1 | 111 | 116 | PF05994 | 0.315 |
MOD_CDC14_SPxK_1 | 238 | 241 | PF00782 | 0.538 |
MOD_CDK_SPxK_1 | 235 | 241 | PF00069 | 0.523 |
MOD_CK1_1 | 231 | 237 | PF00069 | 0.677 |
MOD_CK1_1 | 242 | 248 | PF00069 | 0.658 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.662 |
MOD_CK1_1 | 86 | 92 | PF00069 | 0.732 |
MOD_CK2_1 | 115 | 121 | PF00069 | 0.349 |
MOD_CK2_1 | 159 | 165 | PF00069 | 0.280 |
MOD_CK2_1 | 194 | 200 | PF00069 | 0.443 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.640 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.473 |
MOD_GlcNHglycan | 233 | 236 | PF01048 | 0.561 |
MOD_GlcNHglycan | 244 | 247 | PF01048 | 0.615 |
MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.649 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.736 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.361 |
MOD_GSK3_1 | 231 | 238 | PF00069 | 0.609 |
MOD_GSK3_1 | 5 | 12 | PF00069 | 0.627 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.746 |
MOD_NEK2_1 | 153 | 158 | PF00069 | 0.261 |
MOD_NEK2_1 | 16 | 21 | PF00069 | 0.532 |
MOD_NEK2_1 | 179 | 184 | PF00069 | 0.385 |
MOD_NEK2_1 | 35 | 40 | PF00069 | 0.547 |
MOD_NEK2_1 | 61 | 66 | PF00069 | 0.389 |
MOD_NEK2_2 | 154 | 159 | PF00069 | 0.204 |
MOD_PIKK_1 | 19 | 25 | PF00454 | 0.584 |
MOD_PKA_2 | 179 | 185 | PF00069 | 0.459 |
MOD_PKA_2 | 194 | 200 | PF00069 | 0.491 |
MOD_PKA_2 | 213 | 219 | PF00069 | 0.551 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.633 |
MOD_Plk_4 | 147 | 153 | PF00069 | 0.332 |
MOD_ProDKin_1 | 235 | 241 | PF00069 | 0.622 |
TRG_DiLeu_BaEn_2 | 120 | 126 | PF01217 | 0.404 |
TRG_DiLeu_BaEn_2 | 56 | 62 | PF01217 | 0.400 |
TRG_ENDOCYTIC_2 | 123 | 126 | PF00928 | 0.295 |
TRG_ENDOCYTIC_2 | 139 | 142 | PF00928 | 0.397 |
TRG_ENDOCYTIC_2 | 176 | 179 | PF00928 | 0.374 |
TRG_ER_diArg_1 | 1 | 4 | PF00400 | 0.548 |
TRG_ER_diArg_1 | 187 | 189 | PF00400 | 0.530 |
TRG_ER_diArg_1 | 51 | 54 | PF00400 | 0.419 |
TRG_NLS_Bipartite_1 | 163 | 184 | PF00514 | 0.374 |
TRG_Pf-PMV_PEXEL_1 | 187 | 191 | PF00026 | 0.526 |
TRG_Pf-PMV_PEXEL_1 | 69 | 73 | PF00026 | 0.604 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6W5 | Leptomonas seymouri | 63% | 97% |
A0A0S4IXY6 | Bodo saltans | 41% | 100% |
A0A1X0NQ34 | Trypanosomatidae | 55% | 100% |
A0A3S7WR02 | Leishmania donovani | 94% | 100% |
A4H608 | Leishmania braziliensis | 77% | 92% |
A4HUD5 | Leishmania infantum | 94% | 100% |
C9ZVG1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 81% |
E9AN35 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
V5BIH1 | Trypanosoma cruzi | 62% | 100% |